These two authors contributed equally to this manuscript.
The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils – implications for asthma
Article first published online: 18 JAN 2013
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd
Volume 68, Issue 3, pages 304–311, March 2013
How to Cite
The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils – implications for asthma. Allergy 2013; 68: 304–311., , , .
Edited by: Hans-Uwe Simon
- Issue published online: 8 FEB 2013
- Article first published online: 18 JAN 2013
- Manuscript Accepted: 28 OCT 2012
- Swedish Research Council. Grant Numbers: 20854, 10350
- Swedish Strategic Foundation (SSF)
- Swedish Cancer Society
- Thorsten & Ragnar Söderberg's Foundation
- Swedish Heart Lung Foundation
- Stockholm County Council. Grant Number: 20090136
- Karolinska Institutet
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.